Summary & Overview
HCPCS G8397: Dilated Macular or Fundus Exam with Macular Edema Assessment
HCPCS Level II code G8397 denotes a dilated macular or fundus examination with documentation of whether macular edema is present and an assessment of retinopathy severity. Nationally relevant for ophthalmology and retina care, this code supports clinical monitoring of diabetic retinopathy and other retinal conditions where macular edema and retinopathy staging drive treatment decisions and follow-up intervals. Payers commonly addressing coverage and documentation expectations for this service include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare.
Readers will find a concise overview of clinical context and expected sites of service, as well as operational guidance on typical billing considerations and documentation elements tied to G8397. The publication outlines benchmarks for utilization and reimbursement patterns where available, summarizes recent policy updates affecting coverage and medical necessity determinations, and situates the code within common clinical workflows for retinal disease management. It also flags documentation components that payers commonly review for claims adjudication and potential audit triggers.
Data not available in the input: specific ICD-10 pairings, associated taxonomies, related procedure codes, and payer-specific reimbursement rates.
Billing Code Overview
HCPCS Level II code G8397 represents a dilated macular or fundus examination performed with documentation of the presence or absence of macular edema and the level of severity of retinopathy. This procedure is a diagnostic ophthalmic exam focused on retinal evaluation to identify macular edema and to grade retinopathy severity.
Service Type: Diagnostic ophthalmic examination (dilated fundus/macular exam)
Typical Site of Service: Ophthalmology clinic, retina specialty clinic, or outpatient clinic where dilated fundus examinations are performed
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with a history of type 2 diabetes mellitus presents for a dilated macular and fundus examination to evaluate for diabetic retinopathy and macular edema. The clinic workflow begins with patient intake and documentation of visual symptoms (blurry central vision, metamorphopsia, or decreased acuity). An ophthalmic technician performs preliminary visual acuity, intraocular pressure, and dilation with mydriatic drops. The ophthalmologist or retina specialist then performs a comprehensive dilated fundus examination using slit-lamp biomicroscopy with a contact or non‑contact lens and indirect ophthalmoscopy to inspect the macula and peripheral retina. Findings are documented explicitly, including the presence or absence of macular edema, level of severity of retinopathy (none, mild, moderate, severe nonproliferative, or proliferative), and any additional observations (hard exudates, microaneurysms, neovascularization, vitreous hemorrhage). Imaging such as optical coherence tomography (OCT) or fundus photography may be ordered and performed before or after the dilated exam to quantify macular thickness and correlate structural changes. The visit note includes clinical decision-making about follow-up interval, need for intravitreal therapy, laser therapy referral, or urgent intervention if proliferative disease is suspected. Accurate documentation of the dilated macular or fundus exam findings and severity staging supports use of billing code G8397 and informs subsequent diagnostic or therapeutic procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |